Literature DB >> 9060074

High incidence of toxoplasmosis during pregnancy in Nigeria.

T Olusi1, U Gross, J Ajayi.   

Abstract

Sera from 606 women of child-bearing age from the Benue River Basin area of Nigeria were screened by serological tests to determine the incidence of toxoplasmosis in Nigeria; 43.7% had serologic evidence of infection, increasing from 25% in the group of 15 to 18-year-old women to 71.4% in the 39-42 year age group. Using a previously published epidemiological model, the incidence rate for each age group varied from 0.5% for 15 years old women to 5.3% in the age group 37 years, with an overall rate of 1.8%. Extending this model as it applies to the estimation of incidence of infection during pregnancy, a 5.4% expected rate of seroconversion was found.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9060074     DOI: 10.3109/00365549609037978

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

1.  [Serological analysis of toxoplasmosis during pregnancy: risk assessment and perspectives of prenatal screening at the University Hospital of Bobo Dioulasso in Burkina Faso].

Authors:  Sanata Bamba; Der Adolphe Some; Cathy Chemla; Régine Geers; Tinga Robert Guiguemde; Isabelle Villena
Journal:  Pan Afr Med J       Date:  2012-06-22

2.  Seroprevalence of Anti-Toxoplasma gondii Antibodies Among Pregnant Woman in South Khuzestan, Iran.

Authors:  Mohammad Jafar Yad Yad; Nabi Jomehzadeh; Maryam Jafar Sameri; Nooshin Noorshahi
Journal:  Jundishapur J Microbiol       Date:  2014-05-01       Impact factor: 0.747

3.  Toxoplasmosis infection among pregnant women in Africa: A systematic review and meta-analysis.

Authors:  Tamirat Tesfaye Dasa; Teshome Gensa Geta; Ayalnesh Zemene Yalew; Rahel Mezemir Abebe; Henna Umer Kele
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240

4.  Toxoplasma gondii infection: seroprevalence and associated risk factors for women of childbearing age in Osun State, Nigeria.

Authors:  Olaniran Olarinde; Oluyomi A Sowemimo; Ting-Wu Chuang; Chia-Mei Chou; Segun O Olasanmi; Kemisola Ikotun; Olaoluwa P Akinwale; Vincent P Gyang; Timothy Nwafor; Adeola Y Olukosi; Jer-Hwa Chang; Chia-Kwung Fan
Journal:  Pathog Glob Health       Date:  2021-07-13       Impact factor: 3.735

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.